The Medical Advisor

Introduction: Why Oxygen Matters in Cancer A  thorough understanding of the problem is half of the solution —and in cancer, one of the most overlooked problems is  tumor hypoxia  (low oxygen levels inside tumors). Hypoxia isn’t just a byproduct of tumor growth. It actively drives: Treatment resistance Metastasis Immune suppression Aggressive tumor behavior At the center of this process is Hypoxia-inducible factor 1-alpha (HIF-1α), a master regulator that helps cancer cells adapt and survive under low-oxygen conditions. This is where  hyperbaric oxygen therapy (HBOT)  comes in. Credit (1) What Is HBOT and How Does It Work? Hyperbaric oxygen therapy (HBOT) involves breathing 100% oxygen at elevated pressure, dramatically increasing oxygen delivery to tissues. Key anticancer mechanisms: Reverses tumor hypoxia Increases reactive oxygen species (ROS) → cancer cell stress Enhances radiotherapy effectiveness Improves drug penetration Reduces hypoxia-driven resistance...

While commonly used to speed up stubborn wounds and tissue infections, hyperbaric medicine can also be helpful in the treatment of infectious diseases such as post-COVID ( R ) .  It’s also enormously useful for stroke patients . I can't think of a more effective intervention than to get the stroke patient into a series of hyperbaric treatments as quickly as possible. (ViktoriiaNovokhatska/Shutterstock) What's Hyperbaric Oxygen Therapy? Hyperbaric medical therapy began in 1662 by placing patients in a pressurized chamber with regular air, but it would be another 100-plus years before pure oxygen was routinely used. Since then, it has been studied extensively and is currently approved by the U.S. Food and Drug Administration (FDA) for several specific conditions, including wound care, radiation injury, and more. Research and clinical trials are ongoing, exploring its potenti...

Introduction Pancreatic cancer  is among the most aggressive and difficult cancers to treat, particularly in its later stages. Approaches to improve pancreatic cancer therapy are essential as this disease has a very bleak outcome. Approximately 80% of pancreatic cancers are pancreatic ductal adenocarcinomas (PDAC). PDAC is a cancer which is difficult to effectively treat as it is often detected late in the disease process. Almost all PDACs (over 90%) have activating mutations in the  GTPase  gene  KRAS . Pancreatic cancer has a high mortality rate and is often resistant to conventional treatments. Standard therapeutic options include surgical resection, chemotherapy, radiation therapy, and targeted therapy for pancreatic cancer with actionable mutations; yet survival rates remain low due to resistance. Recently, integrative treatment strategies have gained interest, including the repurposing of existing drugs originally developed for non-cancer indications.  Giv...